Brain drug tested: does it work better for men or women with schizophrenia?

NCT ID NCT07122895

Recruiting now Disease control Sponsor: China Medical University Hospital Source: ClinicalTrials.gov ↗

Summary

This study is testing whether a new drug that targets a specific brain receptor works differently for men and women to help control the 'negative symptoms' of schizophrenia, like lack of motivation and social withdrawal. 90 participants with stable schizophrenia will continue their regular medication and be randomly assigned to receive either the experimental drug or a placebo for 12 weeks. Researchers will measure changes in symptoms, thinking skills, and quality of life to see if the treatment is effective and if men and women respond differently.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Department of Psychiatry, China Medical University Hospital
RECRUITING

Taichung, Taiwan

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

SCHIZOPHRENIA